Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Melanoma 5Neoplasm Metastasis 2Carcinoma, Renal Cell 2Uveal Melanoma 1Skin Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Motor Activity 1Lymphoid Interstitial Pneumonia 1Laryngeal Diseases 1Carcinoma, Merkel Cell 1Brain Neoplasms 1

Interventions

Radiotherapy, Intensity-Modulated 1Nivolumab 1Metformin 1Ipilimumab 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Laryngeal Diseases × Ipilimumab × Clear all
NCT03162731 2025-04-29

Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage III-IVB Head and Neck Cancer

Thomas Jefferson University

Phase EARLY_PHASE1 Completed
24 enrolled
Head & Neck

Lymphoid Interstitial Pneumonia, Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡